JP6571069B2 - 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 - Google Patents
環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 Download PDFInfo
- Publication number
- JP6571069B2 JP6571069B2 JP2016517971A JP2016517971A JP6571069B2 JP 6571069 B2 JP6571069 B2 JP 6571069B2 JP 2016517971 A JP2016517971 A JP 2016517971A JP 2016517971 A JP2016517971 A JP 2016517971A JP 6571069 B2 JP6571069 B2 JP 6571069B2
- Authority
- JP
- Japan
- Prior art keywords
- ac6mut
- cells
- vector
- nucleic acid
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y406/00—Phosphorus-oxygen lyases (4.6)
- C12Y406/01—Phosphorus-oxygen lyases (4.6.1)
- C12Y406/01001—Aodenylate cyclase (4.6.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361832759P | 2013-06-07 | 2013-06-07 | |
| US61/832,759 | 2013-06-07 | ||
| PCT/US2014/040948 WO2014197624A1 (en) | 2013-06-07 | 2014-06-04 | Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521708A JP2016521708A (ja) | 2016-07-25 |
| JP2016521708A5 JP2016521708A5 (enExample) | 2017-07-20 |
| JP6571069B2 true JP6571069B2 (ja) | 2019-09-04 |
Family
ID=52008569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016517971A Active JP6571069B2 (ja) | 2013-06-07 | 2014-06-04 | 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11040091B2 (enExample) |
| EP (1) | EP3004343B1 (enExample) |
| JP (1) | JP6571069B2 (enExample) |
| KR (1) | KR20160032090A (enExample) |
| CN (1) | CN105452458A (enExample) |
| AU (1) | AU2014274902B2 (enExample) |
| BR (1) | BR112015030355A8 (enExample) |
| CA (1) | CA2914029A1 (enExample) |
| DK (1) | DK3004343T3 (enExample) |
| HK (1) | HK1222884A1 (enExample) |
| IL (1) | IL242885B (enExample) |
| RU (1) | RU2015155831A (enExample) |
| WO (1) | WO2014197624A1 (enExample) |
| ZA (1) | ZA201508942B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10293059B2 (en) * | 2015-04-09 | 2019-05-21 | Cornell University | Gene therapy to prevent reactions to allergens |
| WO2018080146A2 (ko) * | 2016-10-24 | 2018-05-03 | 광주과학기술원 | 단백질 탈 인산화 효소 1 억제 펩타이드를 포함하는 혈관 질환 치료용 조성물 |
| WO2018090036A1 (en) * | 2016-11-14 | 2018-05-17 | Renova Therapeutics, Inc. | Method of protection for cardiac tissue |
| US11760987B2 (en) | 2017-09-07 | 2023-09-19 | The Regents Of The University Of California | Compositions and methods for the treatment or prevention of heart failure |
| CN111542334B (zh) * | 2017-09-29 | 2024-01-23 | 贝特基因 | 用于预防或治疗心律失常的药物组合物 |
| JP2021526818A (ja) * | 2018-06-08 | 2021-10-11 | ユニバーシティー オブ フロリダ リサーチ ファンデーション， インク． | 心筋症のためのａａｖ心臓遺伝子治療 |
| CN109010799B (zh) * | 2018-07-09 | 2021-07-06 | 沣潮医药科技（上海）有限公司 | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 |
| CN109191052B (zh) * | 2018-10-22 | 2020-09-25 | 山东大学 | 一种多车型车辆路径优化方法、服务器及系统 |
| CA3189740A1 (en) | 2020-07-27 | 2022-02-03 | Anjarium Biosciences Ag | Compositions of dna molecules, methods of making therefor, and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1255822A2 (en) * | 1999-12-27 | 2002-11-13 | The Regents Of The University Of California | Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure |
-
2014
- 2014-06-04 KR KR1020167000315A patent/KR20160032090A/ko not_active Ceased
- 2014-06-04 WO PCT/US2014/040948 patent/WO2014197624A1/en not_active Ceased
- 2014-06-04 EP EP14808138.3A patent/EP3004343B1/en active Active
- 2014-06-04 RU RU2015155831A patent/RU2015155831A/ru not_active Application Discontinuation
- 2014-06-04 HK HK16111093.5A patent/HK1222884A1/zh unknown
- 2014-06-04 DK DK14808138.3T patent/DK3004343T3/en active
- 2014-06-04 CA CA2914029A patent/CA2914029A1/en not_active Abandoned
- 2014-06-04 CN CN201480044190.5A patent/CN105452458A/zh active Pending
- 2014-06-04 US US14/893,905 patent/US11040091B2/en active Active
- 2014-06-04 BR BR112015030355A patent/BR112015030355A8/pt not_active Application Discontinuation
- 2014-06-04 AU AU2014274902A patent/AU2014274902B2/en active Active
- 2014-06-04 JP JP2016517971A patent/JP6571069B2/ja active Active
-
2015
- 2015-12-02 IL IL242885A patent/IL242885B/en active IP Right Grant
- 2015-12-08 ZA ZA2015/08942A patent/ZA201508942B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11040091B2 (en) | 2021-06-22 |
| IL242885B (en) | 2019-12-31 |
| ZA201508942B (en) | 2019-05-29 |
| AU2014274902B2 (en) | 2020-06-04 |
| DK3004343T3 (en) | 2019-02-04 |
| JP2016521708A (ja) | 2016-07-25 |
| EP3004343A1 (en) | 2016-04-13 |
| CA2914029A1 (en) | 2014-12-11 |
| WO2014197624A1 (en) | 2014-12-11 |
| RU2015155831A (ru) | 2017-07-14 |
| AU2014274902A1 (en) | 2015-12-24 |
| RU2015155831A3 (enExample) | 2018-03-28 |
| KR20160032090A (ko) | 2016-03-23 |
| EP3004343B1 (en) | 2018-10-10 |
| BR112015030355A2 (pt) | 2017-07-25 |
| BR112015030355A8 (pt) | 2019-12-24 |
| CN105452458A (zh) | 2016-03-30 |
| US20160101164A1 (en) | 2016-04-14 |
| HK1222884A1 (zh) | 2017-07-14 |
| EP3004343A4 (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6571069B2 (ja) | 環状アデノシン一リン酸−インコンピテントアデニリルシクラーゼならびに心不全を処置するおよび心機能を増大させるための組成物および方法 | |
| JP6562632B2 (ja) | 心血管疾患および他の状態のためのパラクリン遺伝子の全身送達および制御された発現 | |
| Hulot et al. | Gene therapy for the treatment of heart failure: promise postponed | |
| US20160166651A1 (en) | Systemic delivery of virus vectors encoding urocortin-2 and related genes to treat diabetes-related cardiac dysfunctions and congestive heart failure | |
| CN112639108A (zh) | 治疗非综合征性感觉神经性听力损失的方法 | |
| US20220023384A1 (en) | Mybpc3 polypeptides and uses thereof | |
| US11760987B2 (en) | Compositions and methods for the treatment or prevention of heart failure | |
| JP2014218509A (ja) | 遺伝子治療用アデノ随伴ウイルスベクターの長期順行性の心外膜冠動脈注入 | |
| Fargnoli et al. | Gene therapy in heart failure | |
| Adjmi | Cardiomyocyte-Specific Delivery of hPKM2 modRNA via CM-SMRTs Drives Regeneration and Functional Recovery in a Porcine Model of Myocardial Infarction | |
| WO2015153357A1 (en) | Compositions and methods for improving cardiac function | |
| Hajjar | Gene Therapy in Heart Failure | |
| Morine et al. | Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170602 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170602 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180328 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180622 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180827 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180928 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190510 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190709 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190731 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190802 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190807 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6571069 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |